3-(2-Iodobenzyl)-2-(pyridin-4-yl)oxazolidine (2)
2774 (m) (C–H), 1653 (s), 1601 (s), 1558 (m), 1497 (w), 1412 (s),
1367 (s), 1265 (s), 1217 (s), 1094 (m), 1080 (m), 1065 (m), 995
(w), 976 (w), 945 (s), 905 (w), 837 (m), 754 (s), 676 (s) and 667
(s); dH (400 MHz; CDCl3) 4.09 (2H, t, J = 9.5, CH2N), 4.46
(2H, t, J = 9.5, CH2O) and 7.77, 8.70 (2 ¥ 2H, AA¢BB¢, J = 6,
pyridineCH); dC (100 MHz; CDCl3) 55.1 (CH2N), 68.0 (CH2O),
121.9 (pyridineCH), 135.1 (pyridine ipsoC), 150.2 (pyridineCH)
and 163.0 (N = C–O); m/z (EI) 148 (M+, 37%), 118 (100), 91 (32),
4-Pyridinecarboxaldehyde 4 (610 ml, 6.4 mmol) was added to a
stirred solution of 2-(2-iodobenzylamino)ethanol9 3 (2.00 g, 7.2
mmol) in tetrahydrofuran (50 cm3) containing anhydrous mag-
nesium sulfate (2.00 g, 16.6 mmol), under a nitrogen atmosphere.
After stirring for 18 h, the reaction mixture was filtered, the solvent
was evaporated in vacuo and the residue dissolved in ethyl acetate
(30 cm3). The resulting solution was washed with aqueous sodium
metabisulfite solution (20% w/v, 5 ¥ 10 cm3), dried (magnesium
sulfate), filtered and evaporated in vacuo to give 2 (2.25 g, 85%)
as a yellow oil (Found MH+ (CI) 367.0299, C15H16IN2O requires
367.0307); nmax(thin film)/cm-1 3112–2767 (m) (C–H), 1599 (s),
1562 (w), 1466 (m), 1437 (m), 1410 (s), 1385 (w), 1342 (m), 1317
(m), 1234 (m), 1200 (w), 1159 (w), 1124 (m), 1101 (m), 1063 (s),
1036 (s), 1013 (s), 993 (m), 904 (w), 814 (m), 784 (m), 752 (s) and
638 (m); dH (400 MHz; CDCl3) 2.88 (1H, m, NCHHCH2), 3.08
(1H, m, NCHHCH2), 3.76, 3.86 (2 ¥ 1H, AB, J = 14, ArCH2),
3.96 (1H, m, CHHO), 4.07 (1H, m, CHHO), 5.27 (1H, s, NCHO),
6.95 (1H, dt, J = 1.5 and 7.5, arylCH), 7.31 (1H, dt, J = 1 and 7.5,
arylCH), 7.41–7.47 (3H, complex, arylCH and 2 x pyridineCH),
7.83 (1H, dd, J = 1 and 8, arylCH) and 8.56 (2H, part of AA¢BB¢,
J = 6, pyridineCH); dC (100 MHz; CDCl3) 51.2 (NCH2CH2),
61.7 (CH2O), 64.6 (ArCH2), 95.4 (NCHO), 100.1 (arylCI), 122.2
(pyridineCH), 128.2, 129.1, 130.2, 139.7 (arylCH), 140.5 (aryl
ipsoC) and 149.8 (pyridineCH); m/z (EI) 366 (M+, 3%), 288 (100),
217 (85), 149 (12), 135 (19), 119 (25), 91 (68), 90 (66), 89 (43), 78
(32, 77 (22), 65 (33), 63 (25), 51 (40) and 39 (26); m/z (CI) 367
(MH+, 11%), 241 (21), 149 (100), 134 (12), 108 (31), 107 (23), 106
(17), 94 (43), 80 (19) and 72 (9).
+
84 (35), 78 (44), 51 (60), 49 (53) and 40 (35); m/z (CI) 166 (MNH4 ,
8%) and 149 (MH+, 100).
Crystal structure determination for compound 5
˚
Crystal data at 120(2) K with Mo-Ka (l = 0.71073 A). 5: M =
478.58, monoclinic, P21/c, a◦= 8.9276(2), b = 14.35482(2), c =
3
˚
˚
10.1033(4) A, b = 109.570(2) , V = 1236.42(7) A , Z = 2, 8639
measured reflections, 2801 unique reflections (Rint = 0.0467), R =
0.0412, wR = 0.1158.
2-(Pyridin-4-yl)-4,5-dihydrooxazole (6)
tert-Butyl acrylate (240 ml, 1.64 mmol) was added to a stirred so-
lution of 3-(2-iodobenzyl)-2-(pyridin-4-yl)oxazolidine 2 (200 mg,
0.55 mmol) in degassed benzene (10 cm3) and the resulting
solution was heated to reflux under a nitrogen atmosphere.
A solution of tributyltin hydride (510 ml, 1.90 mmol) and
2,2¢-azobisisobutyronitrile (44.8 mg, 0.27 mmol) in degassed
benzene (10 cm3) was added dropwise (using a syringe pump)
over a period of 5 h, after which time heating under reflux
was continued for a further 18 h. The solvent was removed
in vacuo and the resulting residue was purified by flash chromatog-
raphy on silica gel (ethyl acetate) to give 6 (47.6 mg, 59%) as an
orange oil. Data as reported above.
3,3¢-Dibenzyl-2,2¢-di(pyridin-4-yl)-2,2¢-bioxazolidine (5)
Tributyltin hydride (840 ml, 3.1 mmol) was added to a stirred,
degassed solution of 3-(2-iodobenzyl)-2-(pyridin-4-yl)oxazolidine
2 (275.6 mg, 0.75 mmol) and 2,2¢-azobisisobutyronitrile (12.0 mg,
73.1 mmol) in benzene (50 cm3). After stirring under reflux under a
nitrogen atmosphere for 18 h, the solvent was removed in vacuo and
the crude product was purified by flash chromatography on silica
gel (50% petroleum ether–50% ethyl acetate) to give 5 (15.1 mg,
8%) as a pale yellow, crystalline solid (Found MH+ (CI) 479.2439,
C30H31N4O2 requires 479.2447); nmax(thin film)/cm-1 3127–2783
(m) (C–H), 1734 (m), 1635 (s), 1549 (w), 1497 (w), 1456 (m), 1426
(m), 1410 (m), 1369 (w), 1281 (s), 1217 (w), 1124 (w), 1065 (m),
833 (w), 756 (s), 700 (m) and 667 (m); dH (400 MHz; CDCl3) 2.14
(2H, m, 2 ¥ NCHHCH2), 2.68 (2H, 2 ¥ CHHO), 3.18, 4.84 (2
¥ 2H, AB, J = 13, 2 ¥ PhCH2), 3.78 (2H, m, NCHHCH2), 4.07
(2H, m, CHH2O), 6.83–6.88 (4H, complex, phenylCH), 7.13–7.18
(6H, complex, phenylCH) and 7.76, 8.71 (2 ¥ 4H, AA¢BB¢, J =
6, pyridineCH); dC (100 MHz; CDCl3) 48.3 (NCH2CH2), 53.6
(CH2O), 66.1 (PhCH2), 99.2 (NCO), 124.3 (pyridineCH), 126.8,
127.7, 128.2 (phenylCH), 139.2 phenyl ipsoC), 148.0 (pyridine
ipsoC) and 149.0 (pyridineCH); m/z (EI) 239 (3%), 162 (18), 148
(14), 118 (27), 106 (21), 91 (100), 84 (24), 78 (30), 65 (19), 51
(39), 49 (41) and 41 (23); m/z (CI) 479 (MH+, 1%), 241 (23), 239
(15), 149 (100), 134 (18), 108 (18), 106 (17), (94 (15) and 80 (25).
A second fraction contained 2-(pyridin-4-yl)-4,5-dihydrooxazole
6 (3.8 mg, 3%), obtained as an orange oil (Found MH+ (ES+)
149.0716, C8H9N2O requires 149.0715); nmax(thin film)/cm-1 3128–
2,5-Dioxopyrrolidin-1-yl isonicotinate (15)14
N-(3-Dimethylaminopropyl)-N¢-ethylcarbodiimide
hydrochloride (5.00 g, 26.1 mmol) was added to a stirred
solution of isonicotinic acid 14 (3.21 g, 26.1 mmol) in
N,N-dimethylformamide (60 cm3) at 0 ◦C, followed by N-
hydroxysuccinimide (3.00 g, 26.1 mmol). After stirring at this
temperature for 2 h, the reaction mixture was poured into
ethyl acetate (70 cm3) and the resulting solution was washed
successively with water (30 cm3), saturated aqueous sodium
bicarbonate solution (30 cm3) and saturated aqueous sodium
chloride solution (30 cm3). The separated organic phase was then
dried (magnesium sulfate), filtered and evaporated in vacuo to
give 15 (3.47 g, 60%) as a white, crystalline solid (Found MH+
◦
(ES+) 221.0560, C10H9N2O4 requires 221.0562); mp 115–120 C;
n
max(KBr disc)/cm-1 3331–2806 (s) (C–H), 1782 (m) (C O), 1716
(s) (C O), 1614 (w), 1521 (w), 1475 (w), 1412 (m), 1336 (w),
1306 (m), 1215 (s), 1078 (s), 1027 (s), 944 (m), 930 (m) and 856
(m); dH (400 MHz; CDCl3) 2.93 (4H, s, CH2CH2) and 7.94, 8.88
(2 ¥ 2H, AA¢BB¢, J = 6, pyridineCH); dC (100 MHz; CDCl3) 25.7
(CH2CH2), 123.2 (pyridineCH), 132.6 (pyridine ipsoC), 151.0
(pyridineCH), 160.8 (ester C = O) and 168.6 (imide C = O); m/z
(EI) 220 (MH+, 1%), 106 (100), 78 (79), 51 (63), 50 (33) and 42
(9); m/z (CI) 221 (MH+, 88%), 141 (12), 138 (51), 124 (100), 123
(32), 108 (8), 91 (16), 80 (41) and 74 (9).
This journal is
The Royal Society of Chemistry 2010
Org. Biomol. Chem., 2010, 8, 4653–4665 | 4659
©